Research Square
An Open-Label Single-Arm Phase I/IIa Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte ® for the Treatment of Knee Osteoarthritis
Preprint: trial in peopleInterventions
The paper
Burjeel Hospital; Karolinska Institutet
Research Square, 25 Aug 2026, Preprint, not peer-reviewed
